Veritas Genetics

From Wikipedia, the free encyclopedia
Veritas Genetics
TypePrivate
IndustryBiotechnology
Personal genomics
Founded2014
FoundersGeorge M. Church
Mirza Cifric
Preston Estep
Jonathan Zhao
Headquarters
Danvers, Massachusetts
,
United States
Key people
Mirza Cifric (CEO)
Preston Estep (Chief Scientific Officer)
ProductsmyGenome
Websitewww.veritasgenetics.com

Veritas Genetics is a personal genomics startup based in Danvers, Massachusetts.[1] It was co-founded in 2014 by George M. Church, , Preston Estep, and Jonathan Zhao.[2]

In 2018, the company launched its flagship product, myGenome, with the stated goal of providing consumers with information about their genetic risk for disease and allergic reactions based on whole-genome sequencing results. The company's decision to sell the product for only $199 per order during an initial period attracted media attention as this promotional price was far below traditional prices for consumer-grade genome sequencing at the time.[1][3][4][5][6]

CNBC included the company on its Disruptor 50 list in 2018[1] and 2019.[7]

In December 2019, the company announced that it was ceasing U.S. operations and laying off most of its employees due to its inability to raise further funding.[8]

In January 2020, the company reversed course and announced that it had obtained further funding, would resume U.S. operations, and would rehire many of its employees.[9]

References[]

  1. ^ a b c "Veritas Genetics 2018 Disruptor 50". CNBC. 2018-05-22. Retrieved 2019-07-02.
  2. ^ "Why Are We Here?". Veritas Genetics. Retrieved 2019-07-01.
  3. ^ Khan, Razib; Mittelman, David (December 2018). "Consumer genomics will change your life, whether you get tested or not". Genome Biology. 19 (1): 120. doi:10.1186/s13059-018-1506-1. ISSN 1474-760X. PMC 6100720. PMID 30124172.
  4. ^ Regalado, Antonio (2016-03-04). "One DNA Test to Rule Them All". MIT Technology Review. Retrieved 2019-07-02.
  5. ^ Molteni, Megan (2018-11-19). "Now You Can Sequence Your Whole Genome for Just $200". Wired. ISSN 1059-1028. Retrieved 2019-07-02.
  6. ^ Andrews, Joe (2019-07-01). "23andMe competitor Veritas Genetics slashes price of whole genome sequencing 40% to $600". CNBC. Retrieved 2019-07-02.
  7. ^ "Veritas 2019 Disruptor 50". CNBC. 2019-05-15. Retrieved 2019-07-02.
  8. ^ Farr, Christina (2019-12-05). "Veritas Genetics, the start-up that can sequence a human genome for less than $600, ceases US operations and is in talks with potential buyers". CNBC. Retrieved 2020-11-18.
  9. ^ "Veritas Genetics Restarts US Business With Near-Term Financing". GenomeWeb. Retrieved 2020-11-18.

External links[]

Stub icon

This article about a technological corporation or company is a stub. You can help Wikipedia by .

  • v
  • t
Retrieved from ""